Basic Science Research in Thermal Ablation

Surgical Oncology Clinics of North America

Volumn 20, Issue 2, 2011, Pages 237-258

  Ahmed, Muneeb ^a   Goldberg, S Nahum ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bioheat equation; Minimally invasive surgery; Radiofrequency; Thermal ablation

Indexed keywords

ARSENIC TRIOXIDE; DOXORUBICIN; HALOTHANE; PACLITAXEL; QUERCETIN; VASOPRESSIN;

ABLATION THERAPY; BREAST ADENOCARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COMPUTER MODEL; DEVICE THERAPY; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ELECTRIC CONDUCTIVITY; HEAT TREATMENT; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INTERMETHOD COMPARISON; LIPOSOMAL DELIVERY; LIVER CANCER; LIVER TUMOR; MEDICAL RESEARCH; MICROELECTRODE; MINIMALLY INVASIVE PROCEDURE; NONHUMAN; RADIOFREQUENCY ABLATION; REPRODUCIBILITY; REVIEW; SARCOMA; TEMPERATURE SENSITIVITY; THERAPY EFFECT; THERMAL CONDUCTIVITY; TISSUE PERFUSION; TUMOR ABLATION; TUMOR LOCALIZATION; TUMOR MODEL; TUMOR VOLUME;

ABLATION TECHNIQUES; BIOMEDICAL RESEARCH; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS;

EID: 79952159599     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.11.011     Document Type: Review

References (95)

1. Gervais D.A., McGovern F.J., Arellano R.S., et al. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003, 226:417-424.
2. Kurup A.N., Callstrom M.R. Ablation of skeletal metastases: current status. J Vasc Interv Radiol 2010, 21:S242-S250.
3. Livraghi T., Meloni F., Goldberg S.N., et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000, 214:761-768.
4. Solbiati L., Livraghi T., Goldberg S.N., et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long term results in 117 patients. Radiology 2001, 221:159-166.
5. Venkatesan A.M., Locklin J., Dupuy D.E., et al. Percutaneous ablation of adrenal tumors. Tech Vasc Interv Radiol 2010, 13:89-99.
6. Zemlyak A., Moore W.H., Bilfinger T.V. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010, 211:68-72.
7. McWilliams J.P., Yamamoto S., Raman S.S., et al. Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol 2010, 21:S204-S213.
8. Dodd G.D., Soulen M.C., Kane R.A., et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000, 20:9-27.
9. Shimada K., Sakamoto Y., Esaki M., et al. Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy. Am J Surg 2008, 195:775-781.
10. Gervais D.A., McGovern F.J., Arellano R.S., et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005, 185:64-71.
11. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005, 234:961-967.
12. Lencioni R., Crocetti L., Cioni R., et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008, 9:621-628.
13. Dodd G.D., Frank M.S., Aribandi M., et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001, 177:777-782.
14. Goldberg S.N., Grassi C.J., Cardella J.F., et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009, 20:S377-S390.
15. Schramm W., Yang D., Haemmerich D. Contribution of direct heating, thermal conduction and perfusion during radiofrequency and microwave ablation. Conf Proc IEEE Eng Med Biol Soc 2006, 1:5013-5016.
16. Ahmed M., Liu Z., Humphries S., et al. Computer modeling of the combined effects of perfusion, electrical conductivity, and thermal conductivity on tissue heating patterns in radiofrequency tumor ablation. Int J Hyperthermia 2008, 24:577-588.
17. Seegenschmiedt M., Brady L., Sauer R. Interstitial thermoradiotherapy: review on technical and clinical aspects. Am J Clin Oncol 1990, 13:352-363.
18. Trembley B., Ryan T., Strohbehn J. Interstitial hyperthermia: physics, biology, and clinical aspects. Hyperthermia and Oncology 1992, vol. 3. VSP, Utrecht (The Netherlands), p. 11-98.
19. Larson T., Bostwick D., Corcia A. Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissues in patients with benign prostatic hyperplasia. Urology 1996, 47:463-469.
20. Zevas N., Kuwayama A. Pathologic analysis of experimental thermal lesions: comparison of induction heating and radiofrequency electrocoagulation. J Neurosurg 1972, 37:418-422.
21. Goldberg S.N., Gazelle G.S., Compton C.C., et al. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000, 88:2452-2463.
22. Goldberg S.N., Gazelle G.S., Halpern E.F., et al. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996, 3:212-218.
23. Mertyna P., Dewhirst M.W., Halpern E., et al. Radiofrequency ablation: the effect of distance and baseline temperature on thermal dose required for coagulation. Int J Hyperthermia 2008, 24:550-559.
24. Mertyna P., Hines-Peralta A., Liu Z.J., et al. Radiofrequency ablation: variability in heat sensitivity in tumors and tissues. J Vasc Interv Radiol 2007, 18:647-654.
25. Goldberg S.N., Gazelle G.S., Dawson S.L., et al. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995, 2:399-404.
26. Pennes H. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1948, 1:93-122.
27. Goldberg S.N., Gazelle G.S., Mueller P.R. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000, 174:323-331.
28. Goldberg S.N., Stein M., Gazelle G.S., et al. Percutaneous radiofrequency tissue ablation: optimization of pulsed-RF technique to increase coagulation necrosis. J Vasc Interv Radiol 1999, 10:907-916.
29. Goldberg S.N., Solbiati L., Hahn P.F., et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998, 209:371-379.
30. Gulesserian T., Mahnken A.H., Schernthaner R., et al. Comparison of expandable electrodes in percutaneous radiofrequency ablation of renal cell carcinoma. Eur J Radiol 2006, 59:133-139.
31. Brace C.L., Sampson L.A., Hinshaw J.L., et al. Radiofrequency ablation: simultaneous application of multiple electrodes via switching creates larger, more confluent ablations than sequential application in a large animal model. J Vasc Interv Radiol 2009, 20:118-124.
32. Laeseke P.F., Sampson L.A., Haemmerich D., et al. Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results. Radiology 2006, 241:116-124.
33. Brace C.L., Laeseke P.F., Sampson L.A., et al. Radiofrequency ablation with a high-power generator: device efficacy in an in vivo porcine liver model. Int J Hyperthermia 2007, 23:387-394.
34. Solazzo S.A., Ahmed M., Liu Z., et al. High-power generator for radiofrequency ablation: larger electrodes and pulsing algorithms in bovine ex vivo and porcine in vivo settings. Radiology 2007, 242:743-750.
35. Laeseke P.F., Lee F.T., Sampson L.A., et al. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol 2009, 20:1224-1229.
36. Goldberg S.N., Gazelle G.S., Dawson S.L., et al. Radiofrequency tissue ablation using multiprobe arrays: greater tissue destruction than multiple probes operating alone. Acad Radiol 1995, 2:670-674.
37. Bangard C., Rosgen S., Wahba R., et al. Large-volume multi-tined expandable RF ablation in pig livers: comparison of 2D and volumetric measurements of the ablation zone. Eur Radiol 2010, 20:1073-1078.
38. Rossi S., Buscarini E., Garbagnati F. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998, 170:1015-1022.
39. Siperstein A.E., Rogers S.J., Hansen P.D., et al. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997, 122:1147-1155.
40. Leveen R.F. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Intervent Radiol 1997, 12:313-324.
41. Appelbaum L., Sosna J., Pearson R., et al. Algorithm optimization for multitined radiofrequency ablation: comparative study in ex vivo and in vivo bovine liver. Radiology 2010, 254:430-440.
42. McGahan J.P., Gu W.Z., Brock J.M., et al. Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol 1996, 3(5):418-422.
43. Desinger K., Stein T., Muller G., et al. Interstitial bipolar RF-thermotherapy (REITT) therapy by planning by computer simulation and MRI-monitoring-a new concept for minimally invasive procedures. Proc SPIE 1999, 3249:147-160.
44. Lee J.M., Han J.K., Kim S.H., et al. Bipolar radiofrequency ablation using wet-cooled electrodes: an in vitro experimental study in bovine liver. AJR Am J Roentgenol 2005, 184:391-397.
45. Seror O., N'Kontchou G., Ibraheem M., et al. Large (>or = 5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes-initial experience in 26 patients. Radiology 2008, 248:288-296.
46. Lee J.M., Han J.K., Kim H.C., et al. Multiple-electrode radiofrequency ablation of in vivo porcine liver: comparative studies of consecutive monopolar, switching monopolar versus multipolar modes. Invest Radiol 2007, 42:676-683.
47. Goldberg S.N., Gazelle G.S., Solbiati L., et al. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996, 3:636-644.
48. Cha J., Choi D., Lee M.W., et al. Radiofrequency ablation zones in ex vivo bovine and in vivo porcine livers: comparison of the use of internally cooled electrodes and internally cooled wet electrodes. Cardiovasc Intervent Radiol 2009, 32:1235-1240.
49. Hines-Peralta A., Hollander C.Y., Solazzo S., et al. Hybrid radiofrequency and cryoablation device: preliminary results in an animal model. J Vasc Interv Radiol 2004, 15:1111-1120.
50. Cheng Z., Xiao Q., Wang Y., et al. 915MHz microwave ablation with implanted internal cooled-shaft antenna: initial experimental study in in vivo porcine livers. Eur J Radiol 2010, [Epub ahead of print].
51. He N., Wang W., Ji Z., et al. Microwave ablation: an experimental comparative study on internally cooled antenna versus non-internally cooled antenna in liver models. Acad Radiol 2010, 17:894-899.
52. Monsky W.L., Kruskal J.B., Lukyanov A.N., et al. Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 2002, 224:823-829.
53. Patterson E.J., Scudamore C.H., Owen D.A., et al. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998, 227:559-565.
54. Goldberg S.N., Hahn P.F., Halpern E.F., et al. Radiofrequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998, 209:761-769.
55. Hines-Peralta A., Sukhatme V., Regan M., et al. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Radiology 2006, 240:82-89.
56. Hakime A., Hines-Peralta A., Peddi H., et al. Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology 2007, 244:464-470.
57. Liu Z., Ahmed M., Weinstein Y., et al. Characterization of the RF ablation-induced 'oven effect': the importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia 2006, 22:327-342.
58. Aube C., Schmidt D., Brieger J., et al. Influence of NaCl concentrations on coagulation, temperature, and electrical conductivity using a perfusion radiofrequency ablation system: an ex vivo experimental study. Cardiovasc Intervent Radiol 2007, 30:92-97.
59. Miao Y., Ni Y., Yu J., et al. A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol 2000, 35:438-444.
60. Gillams A.R., Lees W.R. CT mapping of the distribution of saline during radiofrequency ablation with perfusion electrodes. Cardiovasc Intervent Radiol 2005, 28:476-480.
61. Liu Z., Lobo S.M., Humphries S., et al. Radiofrequency tumor ablation: insight into improved efficacy using computer modeling. AJR Am J Roentgenol 2005, 184:1347-1352.
62. Laeseke P.F., Sampson L.A., Winter T.C., et al. Use of dextrose 5% in water instead of saline to protect against inadvertent radiofrequency injuries. AJR Am J Roentgenol 2005, 184:1026-1027.
63. Ahmed M., Goldberg S.N. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia 2004, 20:781-802.
64. Horkan C., Dalal K., Coderre J.A., et al. Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology 2005, 235:81-88.
65. Goldberg S.N., Hahn P.F., Tanabe K.K., et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol 1998, 9:101-111.
66. Goldberg S.N., Kamel I.R., Kruskal J.B., et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol 2002, 179:93-101.
67. Head H.W., Dodd G.D., Bao A., et al. Combination radiofrequency ablation and intravenous radiolabeled liposomal doxorubicin: imaging and quantification of increased drug delivery to tumors. Radiology 2010, 255:405-414.
68. Kang S.G., Yoon C.J., Jeong S.H., et al. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. J Vasc Interv Radiol 2009, 20:1570-1577.
69. Goldberg S.N., Saldinger P.F., Gazelle G.S., et al. Percutaneous tumor ablation: increased coagulation necrosis with combined radiofrequency and percutaneous doxorubicin injection. Radiology 2001, 220:420-427.
70. Ahmed M., Liu Z., Lukyanov A.N., et al. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology 2005, 235:469-477.
71. Vaage J., Barbara E. Tissue uptake and therapeutic effects of stealth doxorubicin. Stealth liposomes 1995, CRC Press, Inc, Boca Raton (FL). D. Lasic, F. Martin (Eds.).
72. Gabizon A., Shiota R., Papahadjopoulos D. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst 1989, 81:1484-1488.
73. Ranson M.R., Carmichael J., O'Byrne K., et al. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol 1997, 15:3185-3191.
74. Gordon A.N., Granai C.O., Rose P.G., et al. Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer. J Clin Oncol 2000, 18:3093-3100.
75. Rivera E., Valero V., Arun B., et al. Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer. J Clin Oncol 2003, 21:3249-3254.
76. Ahmed M., Monsky W.E., Girnun G., et al. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Cancer Res 2003, 63:6327-6333.
77. D'Ippolito G., Ahmed M., Girnun G.D., et al. Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model. Radiology 2003, 228:112-118.
78. Monsky W.E., Goldberg S.N., Lukyanov A.N., et al. Radiofrequency tumor ablation increases intratumoral liposomal doxorubicin accumulation in an animal breast tumor model. Radiology 2002, 224(3):823-829.
79. Poon R.T., Borys N. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 2009, 10:333-343.
80. Solazzo S., Ahmed M., Schor-Bardach R., et al. Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology 2010, 225(1):62-74.
81. Yang W., Ahmed M., Elian M., et al. Do liposomal apoptotic enhancers increase tumor coagulation and endpoint survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?. Radiology 2010, 257(3):685-696.
82. Yang W., Ahmed M., Tasawwar B., et al. Radiofrequency (RF) ablation combined with adjuvant liposomal quercetin-induced heat shock protein suppression increases tumor destruction and end-point survival in a rat animal model [abstract]. Presented at the Annual Meeting of the Society of Thermal Medicine. 2010, p. 105.
83. Dromi S., Frenkel V., Luk A., et al. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res 2007, 13:2722-2727.
84. Dupuy D.E., DiPetrillo T., Gandhi S., et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006, 129:738-745.
85. Algan O., Fosmire H., Hynynen K., et al. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer 2000, 89:399-403.
86. Solazzo S., Mertyna P., Peddi H., et al. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model. Int J Hyperthermia 2008, 24:560-567.
87. Mayer R., Hamilton-Farrell M.R., van der Kleij A.J., et al. Hyperbaric oxygen and radiotherapy. Strahlenther Onkol 2005, 181:113-123.
88. Wood B.J., Kruecker J., Abi-Jaoudeh N., et al. Navigation systems for ablation. J Vasc Interv Radiol 2010, 21:S257-S263.
89. Krucker J., Xu S., Glossop N., et al. Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol 2007, 18:1141-1150.
90. Klauser A.S., De Zordo T., Feuchtner G.M., et al. Fusion of real-time US with CT images to guide sacroiliac joint injection in vitro and in vivo. Radiology 2010, 256:547-553.
91. Khan M.F., Dogan S., Maataoui A., et al. Navigation-based needle puncture of a cadaver using a hybrid tracking navigational system. Invest Radiol 2006, 41:713-720.
92. Aravalli R.N., Golzarian J., Cressman E.N. Animal models of cancer in interventional radiology. Eur Radiol 2009, 19:1049-1053.
93. Haemmerich D., Lee F.T. Multiple applicator approaches for radiofrequency and microwave ablation. Int J Hyperthermia 2005, 21:93-106.
94. dos Santos I., Haemmerich D., Pinheiro Cda S., et al. Effect of variable heat transfer coefficient on tissue temperature next to a large vessel during radiofrequency tumor ablation. Biomed Eng Online 2008, 7:21.
95. Gasselhuber A., Dreher M.R., Negussie A., et al. Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperthermia 2010, 26:499-513.